Table 3.
Donor region (DR)a | 6WK | 9WK | G26 | G29 | NA | TF | AI |
Proximal (2P) | |||||||
DR | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 | 0.0079 |
HG | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 |
Sex | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 | 0.9840 |
DR*HG | <.0001 | 0.0094 | <.0001 | 0.0181 | <.0001 | 0.0004 | 0.0183 |
DR*sex | 0.0287 | 0.4783 | 0.0328 | 0.5938 | 0.0081 | 0.8780 | 0.5218 |
DR*HG*Sex | 0.4092 | 0.4206 | 0.6957 | 0.0882 | 0.1563 | 0.1618 | 0.0219 |
Proximal middle (2PM) | |||||||
DR | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 |
HG | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 |
Sex | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 | 0.7248 |
DR*HG | 0.7101 | 0.4667 | 0.1277 | 0.1110 | 0.7375 | 0.0026 | 0.0065 |
DR*sex | 0.1441 | 0.3947 | 0.1095 | 0.4198 | 0.0104 | 0.9323 | 0.6994 |
DR*HG*Sex | 0.9437 | 0.2294 | 0.5748 | 0.0780 | 0.7697 | 0.0060 | 0.0002 |
Middle (2M) | |||||||
DR | 0.007 | <.0001 | 0.0234 | 0.0002 | 0.0006 | 0.1703 | 0.9707 |
HG | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 |
Sex | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 | 0.0064 |
DR*HG | 0.0057 | 0.0563 | 0.1875 | 0.6072 | 0.4329 | 0.3437 | 0.0256 |
DR*sex | 0.6968 | 0.0089 | 0.8356 | 0.0207 | 0.5162 | 0.1460 | 0.0437 |
DR*HG*Sex | 0.6205 | 0.1309 | 0.6500 | 0.0656 | 0.6704 | 0.0035 | 0.0004 |
6WK, weight at 6 weeks of age; 9WK, weight at 9 weeks of age; G26, weight gain from 2 to 6 weeks of age; G29, weight gain from 2 to 9 weeks of age; NA, nasal-anal body length; TF, total fat pad weight and AI, adiposity index. Significant effects after a Bonferroni correction (critical P < 0.0071) are in bold.
a The distal (2D) donor region was not analyzed.